Radioimmunoscintigraphy with 111 Indium Labeled Cyt-356 for the Detection of Occult Prostate Cancer Recurrence-Reference-Cited by-同舟云学术

Radioimmunoscintigraphy with 111 Indium Labeled Cyt-356 for the Detection of Occult Prostate Cancer Recurrence

Published:1994-11 Issue:5 Part 1 Volume:152 Page:1490-1495
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kahn Daniel¹²³,Williams Richard D.¹²³,Seldin David W.¹²³,Libertino John A.¹²³,Hirschhorn Mark¹²³,Dreicer Robert¹²³,Weiner George J.¹²³,Bushnell David¹²³,Gulfo Joseph¹²³

Affiliation:

1. From the Departments of Radiology, Division of Nuclear Medicine, Urology and Internal Medicine, University of Iowa College of Medicine and Veterans Affairs Medical Center, Iowa City, Iowa

2. Departments of Urology and Diagnostic Radiology, Lahey Clinic Medical Center, Burlington, Massachusetts

3. Cytogen Corporation, Princeton, New Jersey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Cancer statistics, 1994;Boring;CA,1994

2. Prostate cancer: screening, diagnosis, and management;Garnick;Ann. Intern. Med.,1993

3. Local failure after definitive radiation or surgical therapy for carcinoma of the prostate and options for prevention and therapy;Schellhammer;Urol. Clin. N. Amer,1991

4. Future role of radiolabeled monoclonal anti bodies in oncological diagnosis and therapy;Goldenberg;Sem. Nucl. Med.,1989

5. Radioimmunology. Imaging and therapy;Larson;Cancer, suppl.,1991

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research Applications;Diagnostics;2023-01-03

2. The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review;Cancers;2022-07-26

3. Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer;International Journal of Molecular Sciences;2021-11-09

4. The History of Prostate-Specific Membrane Antigen as a Theranostic Target in Prostate Cancer: The Foundational Role of the Prostate Cancer Foundation;Journal of Nuclear Medicine;2021-10-21

5. Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer;Current Oncology Reports;2021-03-29